Virtual Drug Development, Inc. Studying Pre-Exposure Antibiotic For Anthrax
Executive Summary
Virtual Drug Development, Inc. is seeking to develop a pre-exposure prophylactic antibiotic for Bacillus anthracis that could serve as an alternative to the current anthrax vaccine.